Conference abstractPublished 26 Jun 2017
Analytical glycomics: Biopharmaceutical applications
University of Debrecen, Hungary
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Full characterization of the N-glycosylation moieties of biopharmaceuticals is of high importance, especially when glycovariants may impact the biological effect. Well over half of the new generation protein therapeutics are monoclonal antibodies, in which the attached oligosaccharides not only affect their physicochemical properties and stability, but also their receptor binding activity, circulating half-life and last but not least, their immunogenicity. Therefore, high performance glycoanalytical techniques are of great demand for N-glycosylation analysis of therapeutic antibodies, especially during clone selection, process development and lot release. Analysis of complex carbohydrates is a very challenging task due to the lack of their chromophore / fluorophore activity and, in many instances, easily ionizable groups, necessitating derivatization before electric field mediated analysis. Full N-glycosylation characterization may also require sequencing with consecutive exoglycosidase digestion steps, followed by capillary electrophoresis analysis. In this presentation the state of the art of liquid phase separation methods will be conferred for comprehensive structural elucidation of protein N-glycosylation, mostly using capillary electrophoresis and its combination with mass spectrometry (CESI-MS). Assisted by the emerging field of glycoinformatics, assignment of the identity of the separated glycan structures will be demonstrated by using the recently introduced GUcal software. Image Figure 1. Glycoanalytical needs during the manufacturing process of recombinant therapeutic proteins References 1. M.Szigeti, C.Lew, K.Roby, A.Guttman, Fully automated sample preparation with ultrafast N-glycosylation analysis of therapeutic antibodies, JALA 21 (2016) 281-286 2. A.Szekrenyes, S.S.Park, M.Santos, B.Warren, A.Jones, E.Cosgrave, T.Haxo, S.Pourkaveh, Z.Szabo, Z.Sosic, P.Feng, Cs.Varadi, JB.Falmagne, P.Sejwal, D.Michels, G.Freckleton, M.Hamm, AManuilov, T.Duffy, M.Schwartz, JK.Luo, J.van Dyck, PK.Leung, M.Olajos, B.Moritz, R.Kowle, G.Kai, W.Wenbo, J.Wegstein, A.Guttman, Multi-Site N-Glycan Mapping Study 1: CE-LIF, mAbs 8 (2016) 56-64. 3. A.Guttman, M.Kerekgyarto, G.Jarvas, The effect of separation temperature on structure specific glycan migration in capillary electrophoresis, Anal.Chem 87 (2015) 11630-11634. 4. C.Lew, JL.Gallegos-Perez, B.Fonslow, A.Guttman, Rapid level-3 characterization of therapeutic antibodies by capillary electrophoresis electrospray ionization mass spectrometry (CESI-MS), J.Chrom.Sci. 53 (2015) 443-449.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectBiochemistry & Biotechnology
- SubjectChemistry
- BylineArticles whose byline prints “Andras Guttman”
